High-dose methotrexate-based regimens and post-remission consolidation for treatment of newly diagnosed primary CNS lymphoma: meta-analysis of clinical trials

With the exception of high-dose methotrexate (HD-MTX), there is currently no defined standard treatment for newly diagnosed primary central nervous system lymphoma (PCNSL). This review focused on first-line induction and consolidation treatment of PCNSL and aimed to determine the optimal combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Junyao, Du, Huaping, Ye, Xueshi, Zhang, Lifei, Xiao, Haowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822904/
https://www.ncbi.nlm.nih.gov/pubmed/33483528
http://dx.doi.org/10.1038/s41598-020-80724-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822904/
https://www.ncbi.nlm.nih.gov/pubmed/33483528
http://dx.doi.org/10.1038/s41598-020-80724-0

Ejemplares similares